Light Chain Deposition Disease — Trials

Light Chain Deposition Disease — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03820817	Rifaximin in Patients With Monoclonal Gammopathy	completed	Phase 1	50	Emory UniversityOTHER	1	May 26, 2026	clinicaltrials
NCT01728259	First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD	terminated	Phase 1	18	Barbara Ann Karmanos Cancer InstituteOTHER	2	May 9, 2023	clinicaltrials
NCT01533194	Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma	completed	Phase 1	12	National Cancer Institute (NCI)NIH	1	Apr 15, 2015	clinicaltrials
NCT00890747	Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Data updated 22 days agoSource updated May 26, 2026source: clinicaltrials